History
Trials
Drugs
Miscellaneous
100

First right heart catheterization of a living human heart was by?

Werner Forssmann

100

. Ezetimibe added to Statin therapy after ACS improved cardiovascular outcomes

IMPROVE IT TRIAL

100

This medication is commonly prescribed for claudication symptoms however should not be prescribed in CHD due to inhibition of phosphodiesterase

Cilostazol

100
  • Distinguishing between AS and HCM, sign seen on invasive simultaneous LV and AO  
  • Brockenbrough-Braunwald-Morrow
200

The word ‘stent’ is named after which dentist?

Charles Stent

200
  • In patients with atrial fibrillation, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism. There was no significant between-group difference in the risk of major bleeding, although intracranial and fatal bleeding occurred less frequently in the rivaroxaban group.
  • – ROCKET-AF trial
200
  •  Mechanism of action of Mavacamten, which has shown in the EXPLORER-HCM trial to improve exercise capacity, LVOT obstruction, and NYHAfunctional class in patients with oHCM
  • Myosine inhibitor
200
  • The PAPI can be used in evaluation of RV failure in cardiogenic shock, what is the evaluation
  • PAsP – PadP/CVP
300

This Professor of physiology from a small Dutch town of Leiden, recorded the first human electrocardiogram?

Willem Einthoven

300
  • In patients with ACS with scheduled PCI, prasugrel vs clopidogrel was associated with reduced rates of ischemic events including stent thrombosis but with increased risk of fatal bleeding, without an overall change in mortality. Name the trial?
  • TRITON-TIMI 38
300

The hemodynamic effect of milrinone include the following increased cardiac output, increased HR, and this effect on systemic vascular resistance

Decrease

300

The gold standard for diagnosing myocardial

Endomyocardial biopsy

400

. In 1952, this Harvard cardiologist developed the first external pacemaker

Zoll

400

For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual chamber pacing offers no clinicaL advantage over ventricular back up pacing and may be detrimental by increasing the end points of death or hospitalization for heart failure

DAVID TRIAL

400
  • 78 yo F presents at an OSH wih CP and 2 mm ST evelation, 4 hours away from PCCI center. Decision is made to give fibrinolytic therapy and transfer to a PCI center. Patient is given ASA 81 mg daily and an additional antiplatelet therapy
  • Clopidogrel 75 mg
400

This genetic mutation of LQT1 syndrome predisposes patients to the following rhythm pattern (Tele strip of polymorphic VT)

KCNQ1 loss of function, potassium genes

500

First HMG COA enzyme inhibitor was isolated by

Akira Endo

500
  • Endoxaban non-inferior to warfarin for stroke prevention and MACE lower with Endoxaban-
  • ENGAGE AF-TIMI 48
500

70 yo F with colon cancer, CAD, HTN, afib presents with hypotension and septic shock/AKI during hospital and found to have this ECG (ECG with bidirectional VT). Please what medication should be discontinued

Digoxin

500

This ECHo scoring system is used to determine the likelihood of success of balloon valvotomy in MS

Wilkins score

M
e
n
u